Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 49 for “"Antiplatelet agents"”.

  1. EFFECTS OF ANTIPLATELET AGENTS ON PLATELETS EXPOSED TO SHEAR STRESS

    … There is evidence that certain drugs, called antiplatelet agents, alter platelet behavior in a way that reduces adhesion, aggregation, and secretion while causing no significant adverse effects on hemostasis. The objective of this study was to investigate the effects of antiplatelet agents on …

    rice Repository record for EFFECTS OF ANTIPLATELET AGENTS ON PLATELETS EXPOSED TO SHEAR STRESS (opens in a new tab)

  2. Effects of antiplatelet agents on polymorphonuclear leukocytes exposed to mechanical trauma

    … or membrane lysis. In addition, the effects of antiplatelet agents on PMN leukocyte response to shear stress were studied. The antiplatelet agents, known to elevate intracellular and cyclic adenosine monophosphate (cAMP), included the following: prostaglandin Ej (PGEi), prostaglandin I2 (PGI2), …

    rice Repository record for Effects of antiplatelet agents on polymorphonuclear leukocytes exposed to mechanical trauma (opens in a new tab)

  3. Improving end organ dysfunction and survival with antiplatelet agents in community acquired pneumonia

    … intensive care unit (ICU)-level organ support. Antiplatelet agents may also favorably modulate host responses; however, their role in COVID-19 and non-COVID-19 CAP remains uncertain. Objectives: The overall objective was to evaluate the treatment effects and safety of antiplatelet agents and …

    manitoba Repository record for Improving end organ dysfunction and survival with antiplatelet agents in community acquired pneumonia (opens in a new tab)

  4. Antiplatelet agents in the secondary prevention of vascular events in adults undergoing percutaneous coronary intervention: Cost-effectiveness, budget impact and research priorities

    … to investigate the cost-effectiveness of various antiplatelet regimens used in the secondary prevention of vascular events in adults undergoing percutaneous coronary intervention (PCI). Analyses include the first economic evaluation to evaluate three antiplatelet regimens (clopidogrel + ASA, …

    ottawa-retro Repository record for Antiplatelet agents in the secondary prevention of vascular events in adults undergoing percutaneous coronary intervention: Cost-effectiveness, budget impact and research priorities (opens in a new tab)

  5. Acute Pharmacological Treatment given to Older Adults with Acute Myocardial Infarction: A Nationwide Emergency Department Study, 1992-2010

    … determine the pattern and predictors of use of antiplatelet agents and beta-blockers given in the emergency department (ED) to older adults with acute myocardial infarction (AMI) and its effects on in-hospital mortality and length of hospital stay (LOS) and to determine the effect of …

    vcu Repository record for Acute Pharmacological Treatment given to Older Adults with Acute Myocardial Infarction: A Nationwide Emergency Department Study, 1992-2010 (opens in a new tab)

  6. Age-related outcome of patients after traumatic brain injury: a single-center observation

    … disease, use of anticoagulants and/or antiplatelet agents, abnormal pupillary reactivity, a high score in Marshall CT classification, and a higher glucose level were associated with unfavorable outcomes in a univariable logistic regression. In a multivariable logistic regression, age …

    zurich Repository record for Age-related outcome of patients after traumatic brain injury: a single-center observation (opens in a new tab) Restricted access

  7. Prevalencia de resistencia plaquetaria a clopidogrel en pacientes sometidos a intervencion coronaria percutanea

    Antiplatelet agents are the mainstay of treatment for patients with syndromes Acute Coronary have shown reduced risk of death, myocardial infarction, and need for urgent revascularization. Some patients have events major cardiac despite receiving these drugs. The impact of resistance drugs has been …

    rosario Repository record for Prevalencia de resistencia plaquetaria a clopidogrel en pacientes sometidos a intervencion coronaria percutanea (opens in a new tab)

  8. The pharmacodynamics of the antiplatelet drug ticagrelor: mode of action, onset and reversibility.

    … birthing the modern standard of care of dual antiplatelet therapy (DAPT) in patients with acute coronary syndromes (ACS). Of the currently available antiplatelet agents, ticagrelor has been shown to be superior both in clinical trials and laboratory studies. However, much debate exists around …

    bristol Repository record for The pharmacodynamics of the antiplatelet drug ticagrelor: mode of action, onset and reversibility. (opens in a new tab) Download PDF for The pharmacodynamics of the antiplatelet drug ticagrelor: mode of action, onset and reversibility. (opens in a new tab)

  9. The management of bleeding in patients hospitalised in the intensive cardio care unit /

    … most appropriate management. Anticoagulants and antiplatelet agents are cornerstones of cardiology and comprehensively used. However, in the case of bleeding events, they are also non-modifiable risk factors. Evidence suggests that bleeding increases all-cause mortality in the same way as …

    vilnius Repository record for The management of bleeding in patients hospitalised in the intensive cardio care unit / (opens in a new tab)

  10. Complications and failures of secondary prevention in acute ischaemic stroke

    … minor ischaemic stroke, including aspirin, other antiplatelet agents, and blood pressure lowering drugs, statins and anticoagulation in atrial fibrillation. However, failure of secondary prevention to prevent recurrent vascular events is still a major clinical problem, as is the risk of bleeding …

    oxford Repository record for Complications and failures of secondary prevention in acute ischaemic stroke (opens in a new tab)

  11. Retrospective evaluation of the rockall risk scoring system in patients with nonvariceal upper gastrointestinal hemorrhage at a community hospital

    … resources utilized and evaluated whether certain antiplatelet agents, anticoagulants, and NSAIDS affected the Rockall scores. The Rockall scoring system identified 21% of patients as having low Rockall scores, with no significant differences in length of stay between risk groups. Our study shows …

    emich Repository record for Retrospective evaluation of the rockall risk scoring system in patients with nonvariceal upper gastrointestinal hemorrhage at a community hospital (opens in a new tab)

  12. High-Risk Medication Use, Frailty and Hospitalization among Older Assisted Living Residents

    … (ii) high-risk (HR) drugs (anticoagulants, oral antiplatelet agents, insulins, and oral hypoglycemic agents), which have been shown to be responsible for the majority of drug-related hospital admissions. Given the risk associated with these medications, medication management and monitoring are …

    waterloo Repository record for High-Risk Medication Use, Frailty and Hospitalization among Older Assisted Living Residents (opens in a new tab)

  13. The vascular effects of clopidogrel

    Dual antiplatelet therapy using aspirin with a purinergic receptor 2Y12 (P2Y12) antagonist is the most common preventative method for arterial thrombosis. The favored P2Y12 antagonist clopidogrel is a prodrug that is absorbed in the intestine and then converted into the active metabolite by …

    msu Repository record for The vascular effects of clopidogrel (opens in a new tab)

  14. Evaluating Risk of Delayed Major Bleeding in Critically Ill Trauma Patients

    … included: male gender, pre-injury use of the antiplatelet agents aspirin and/or clopidogrel, presence of intracranial bleeding, higher injury severity scores, requirement of massive transfusion, and low pH values. Use of anticoagulant prophylaxis was not associated with delayed major bleeding. …

    ottawa-retro Repository record for Evaluating Risk of Delayed Major Bleeding in Critically Ill Trauma Patients (opens in a new tab)

  15. Ανάπτυξη μεθόδων LC-MS/MS για την ανάλυση φυσικών προϊόντων: η περίπτωση της ναρινγενίνης

    … interest for the development of new therapeutic agents. In addition, they can form the basis for synthetic and medicinal chemistry in the context of the development of new derivatives with enhanced biological activity. In particular, flavonoids are considered among the most important NPs due to …

    greece Repository record for Ανάπτυξη μεθόδων LC-MS/MS για την ανάλυση φυσικών προϊόντων: η περίπτωση της ναρινγενίνης (opens in a new tab)

  16. Caracterización de la población que consulta por epistaxis al servicio de Otorrinolaringología del Hospital Universitario Mayor

    … to the group of antihypertensives and 37.6% to antiplatelet agents. The location of the bleeds was anterior (> Cottle area II). The main treatment was the anterior nasal gauze packing (36.4%), followed by silver nitrate cauterization (36.1%). Conclusions: In the HUM, patients who consult for …

    rosario Repository record for Caracterización de la población que consulta por epistaxis al servicio de Otorrinolaringología del Hospital Universitario Mayor (opens in a new tab)

  17. EFFECT OF PRASUGREL IN PATIENTS WITH ASTHMA: RESULTS OF PRINA, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,CROSS-OVER STUDY

    … studies tested the anti-inflammatory effect of antiplatelet agents in humans. The platelet P2Y12 receptors mediated bronchial inflammation in a mouse model of asthma, suggesting that P2Y12 represents a pharmacological target for asthma. Objectives: In this proof-of concept, placebo-controlled, …

    milano Repository record for EFFECT OF PRASUGREL IN PATIENTS WITH ASTHMA: RESULTS OF PRINA, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,CROSS-OVER STUDY (opens in a new tab)

Page 1 of 3